Connection

Perry Halushka to Platelet Aggregation

Back to Details
This is a "connection" page, showing publications Perry Halushka has written about Platelet Aggregation.
Perry Halushka
Connection Strength
1.255
Platelet Aggregation
  1. Castration reduces platelet thromboxane A2 receptor density and aggregability. QJM. 2005 May; 98(5):349-56.
    View in: PubMed
    Score: 0.241
  2. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995 Jun 01; 91(11):2742-7.
    View in: PubMed
    Score: 0.122
  3. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets. Biochem Biophys Res Commun. 1988 Dec 15; 157(2):733-9.
    View in: PubMed
    Score: 0.078
  4. Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther. 2003 Jan; 73(1):122-30.
    View in: PubMed
    Score: 0.051
  5. Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation. Thromb Res. 1981 Nov 15; 24(4):307-17.
    View in: PubMed
    Score: 0.048
  6. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. Proc Natl Acad Sci U S A. 1979 Aug; 76(8):4097-101.
    View in: PubMed
    Score: 0.041
  7. The effects of alpha adrenergic agents on human platelet aggregation. J Pharmacol Exp Ther. 1979 Mar; 208(3):366-70.
    View in: PubMed
    Score: 0.039
  8. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. N Engl J Med. 1977 Dec 15; 297(24):1306-10.
    View in: PubMed
    Score: 0.036
  9. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol. 1994 Sep; 267(3 Pt 2):H887-93.
    View in: PubMed
    Score: 0.029
  10. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension. Thromb Res. 1993 May 01; 70(3):205-10.
    View in: PubMed
    Score: 0.026
  11. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Aug; 262(2):632-7.
    View in: PubMed
    Score: 0.025
  12. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Jul; 262(1):238-45.
    View in: PubMed
    Score: 0.025
  13. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP. Adv Prostaglandin Thromboxane Leukot Res. 1991; 21A:331-7.
    View in: PubMed
    Score: 0.022
  14. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors. Biochem Pharmacol. 1990 Oct 01; 40(7):1457-61.
    View in: PubMed
    Score: 0.022
  15. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction. Circulation. 1990 Jan; 81(1):212-8.
    View in: PubMed
    Score: 0.021
  16. I-BOP, the most potent radiolabelled agonist for the TXA2/PGH2 receptor. Adv Prostaglandin Thromboxane Leukot Res. 1990; 20:102-9.
    View in: PubMed
    Score: 0.021
  17. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. J Pharmacol Exp Ther. 1989 Nov; 251(2):557-62.
    View in: PubMed
    Score: 0.021
  18. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619. J Pharmacol Exp Ther. 1988 Dec; 247(3):1133-8.
    View in: PubMed
    Score: 0.019
  19. Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels. Eur J Pharmacol. 1988 Apr 13; 148(3):309-15.
    View in: PubMed
    Score: 0.019
  20. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant. Biochem Pharmacol. 1987 Jun 15; 36(12):1913-7.
    View in: PubMed
    Score: 0.018
  21. Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets. Prostaglandins. 1987 Jun; 33(6):789-97.
    View in: PubMed
    Score: 0.017
  22. Binding of thromboxane A2/prostaglandin H2 agonists to human platelets. Br J Pharmacol. 1987 May; 91(1):223-7.
    View in: PubMed
    Score: 0.017
  23. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors. Fed Proc. 1987 Jan; 46(1):149-53.
    View in: PubMed
    Score: 0.017
  24. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets. Eur J Pharmacol. 1986 Nov 12; 131(1):49-54.
    View in: PubMed
    Score: 0.017
  25. Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes. J Biol Chem. 1986 Mar 05; 261(7):3025-9.
    View in: PubMed
    Score: 0.016
  26. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. Circulation. 1985 Dec; 72(6):1202-7.
    View in: PubMed
    Score: 0.016
  27. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. J Pharmacol Exp Ther. 1985 Dec; 235(3):729-34.
    View in: PubMed
    Score: 0.016
  28. Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism. 1985 Dec; 34(12 Suppl 1):32-6.
    View in: PubMed
    Score: 0.016
  29. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther. 1985 May; 233(2):418-24.
    View in: PubMed
    Score: 0.015
  30. Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins. Eur J Pharmacol. 1985 Apr 23; 111(1):125-8.
    View in: PubMed
    Score: 0.015
  31. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia. J Cardiovasc Pharmacol. 1985 Jan-Feb; 7(1):114-20.
    View in: PubMed
    Score: 0.015
  32. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30; 75(5B):67-80.
    View in: PubMed
    Score: 0.014
  33. Do platelets have anything to do with diabetic microvascular disease? Diabetes. 1983 May; 32 Suppl 2:14-9.
    View in: PubMed
    Score: 0.013
  34. Thromboxane and prostacyclin in disease: a review. Q J Med. 1983; 52(208):461-70.
    View in: PubMed
    Score: 0.013
  35. Protective effects of aspirin in endotoxic shock. J Pharmacol Exp Ther. 1981 Aug; 218(2):464-9.
    View in: PubMed
    Score: 0.012
  36. Increased platelet arachidonic acid metabolism in diabetes mellitus. Diabetes. 1981; 30(Suppl 2):44-8.
    View in: PubMed
    Score: 0.011
  37. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care. 1981 Jan-Feb; 4(1):121-33.
    View in: PubMed
    Score: 0.011
  38. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus. Horm Metab Res Suppl. 1981; 11:7-11.
    View in: PubMed
    Score: 0.011
  39. Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med. 1981 Jan; 97(1):87-96.
    View in: PubMed
    Score: 0.011
  40. Platelet function in diabetes mellitus. Br J Haematol. 1980 Apr; 44(4):521-6.
    View in: PubMed
    Score: 0.011
  41. Platelet adhesion and aggregation in diabetes mellitus. Metabolism. 1979 Apr; 28(4 Suppl 1):394-400.
    View in: PubMed
    Score: 0.010
  42. Prostaglandins, thromboxanes, and platelet function. Curr Top Hematol. 1979; 2:75-143.
    View in: PubMed
    Score: 0.010
  43. Altered platelet function in diabetes mellitus. Diabetes. 1976; 25(2 SUPPL):826-31.
    View in: PubMed
    Score: 0.008
  44. Decrease in vascular TxA2 receptors in a subgroup of rabbits unresponsive to a TxA2 mimetic. Am J Physiol. 1994 Jun; 266(6 Pt 2):H2320-6.
    View in: PubMed
    Score: 0.007
  45. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes. 1985 Nov; 34(11):1127-33.
    View in: PubMed
    Score: 0.004
  46. A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand. Biochem Pharmacol. 1985 Apr 15; 34(8):1165-70.
    View in: PubMed
    Score: 0.004
  47. Cardiovascular effects of a 4'-methylthio analog of propranolol. J Pharmacol Exp Ther. 1981 Dec; 219(3):685-90.
    View in: PubMed
    Score: 0.003
  48. Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch Intern Med. 1979 Feb; 139(2):225-30.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.